Lecia V. Sequist on Side Effects From Agents for Resistant Lung Cancer

Patients with lung cancer undergoing anatomic lung resections often had one day home return after completing the surgery, but those with a lower socioeconomic status were less likely to leave the hospital the day after surgery.

Lung cancer survivor Terri Conneran shares her story of creating a non-profit to help connect with fellow patients and survivors who have the KRAS biomarker.

Tecentriq plus carboplatin and pemetrexed may improve efficacy in patients with NSCLC with untreated brain metastases, according to results of a phase 2 trial.

A man shares how reading the footnote of a CT scan looking for heart disease alerted him to a mass in his right lung, leading to an unexpected diagnosis of lung cancer.

During chemotherapy, strawberry-flavored Boost and baked potatoes were the only things I would eat — but this nourishment ended up representing much more.

The first patients in a phase 1/2 trial have received a combination of HPN328, an immunotherapy, and Tecentriq for small cell lung cancer.